Nathaniel E. David, Director at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 4,902 shares at $38.16 ($183K) on 2014-01-02, disclosed to the SEC on 2014-01-06.
Scheduled sale ($183k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.33 | 4,302 | $161K | 87.5% |
| 2 | $38.16 | 600 | $23K | 12.5% |
| Total | $37.43 avg | 4,902 | $183K | 100% |
| Filing → |
| KYTH | SELL | 2015-03-10 | $340K | — | Filing → |
| KYTH | SELL | 2015-03-05 | $600K | — | Filing → |
| KYTH | SELL | 2015-03-03 | $76K | — | Filing → |